Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.

BACKGROUND: Artesunate plus sulphadoxine-pyrimethamine (AS+SP) is now first-line treatment for Plasmodium falciparum infection in several south Asian countries, including Afghanistan. Molecular studies provide a sensitive means to investigate the current state of drug susceptibility to the SP compon...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Awab, G, Pukrittayakamee, S, Jamornthanyawat, N, Yamin, F, Dondorp, A, Day, N, White, N, Woodrow, C, Imwong, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	BioMed Central 2013

Míreanna comhchosúla

A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan
de réir: Jamornthanyawat, N, et al.
Foilsithe / Cruthaithe: (2014)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
de réir: Rakmark, K, et al.
Foilsithe / Cruthaithe: (2020)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
de réir: Kasama Rakmark, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
de réir: Karema, C, et al.
Foilsithe / Cruthaithe: (2010)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
de réir: Awab, GR, et al.
Foilsithe / Cruthaithe: (2016)

A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
de réir: Natsuda Jamornthanyawat, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
de réir: Sugaram, R, et al.
Foilsithe / Cruthaithe: (2020)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
de réir: Rungniran Sugaram, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
de réir: Leartsakulpanich, U, et al.
Foilsithe / Cruthaithe: (2002)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
de réir: Awab, G, et al.
Foilsithe / Cruthaithe: (2010)

Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors.
de réir: Preechapornkul, P, et al.
Foilsithe / Cruthaithe: (2010)

Escalating <it>Plasmodium falciparum </it>antifolate drug resistance mutations in Macha, rural Zambia
de réir: Rouse Petrica, et al.
Foilsithe / Cruthaithe: (2008-05-01)

Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.
de réir: Preechapornkul, P, et al.
Foilsithe / Cruthaithe: (2009)

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
de réir: Srisutham, S, et al.
Foilsithe / Cruthaithe: (2022)

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
de réir: Awab, GR, et al.
Foilsithe / Cruthaithe: (2021)

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.
de réir: Suttipat Srisutham, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
de réir: Mayke J A M Oesterholt, et al.
Foilsithe / Cruthaithe: (2009-01-01)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
de réir: Win, AA, et al.
Foilsithe / Cruthaithe: (2016)

Chloroquine-primaquine versus chloroquine alone to treat Vivax malaria in Afghanistan: An open randomized superiority trial.
de réir: Awab, G, et al.
Foilsithe / Cruthaithe: (2017)

Tracing the origins and signatures of selection of antifolate resistance in island populations of <it>Plasmodium falciparum</it>
de réir: Pinto João, et al.
Foilsithe / Cruthaithe: (2010-06-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
de réir: Woodrow Charles J, et al.
Foilsithe / Cruthaithe: (2010-04-01)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
de réir: Dennis W Juma, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Laboratory detection of artemisinin-resistant Plasmodium falciparum.
de réir: Chotivanich, K, et al.
Foilsithe / Cruthaithe: (2014)

Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension.
de réir: Nair, S, et al.
Foilsithe / Cruthaithe: (2002)

Prevalence of chloroquine and antifolate drug resistance alleles in Plasmodium falciparum clinical isolates from three areas in Ghana [version 2; peer review: 2 approved]
de réir: James Abugri, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Limited polymorphism of the Kelch propeller domain in Plasmodium malariae and P. ovale isolates from Thailand.
de réir: Nakeesathit, S, et al.
Foilsithe / Cruthaithe: (2016)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.
de réir: Mukherjee, A, et al.
Foilsithe / Cruthaithe: (2017)

A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates.
de réir: Karthikeyan Ganesan, et al.
Foilsithe / Cruthaithe: (2008-11-01)

Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum.
de réir: Imwong, M, et al.
Foilsithe / Cruthaithe: (2010)

Protein-based signatures of functional evolution in Plasmodium falciparum
de réir: Gardner, K, et al.
Foilsithe / Cruthaithe: (2011)

Protein-based signatures of functional evolution in Plasmodium falciparum.
de réir: Gardner, K, et al.
Foilsithe / Cruthaithe: (2011)

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
de réir: Ghulam R Awab, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Strong protective effect of Mediterranean type glucose-6-phosphate dehydrogenase deficiency against vivax malaria
de réir: Awab, GR, et al.
Foilsithe / Cruthaithe: (2019)

Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar.
de réir: Imwong, M, et al.
Foilsithe / Cruthaithe: (2008)

Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009
de réir: Alegana, V, et al.
Foilsithe / Cruthaithe: (2014)

Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
de réir: A Sowunmi, et al.
Foilsithe / Cruthaithe: (2005-07-01)

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
de réir: Mayxay, M, et al.
Foilsithe / Cruthaithe: (2001)

Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
de réir: Imwong, M, et al.
Foilsithe / Cruthaithe: (2005)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
de réir: Angana Mukherjee, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
de réir: Dondorp, A, et al.
Foilsithe / Cruthaithe: (2009)